Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis

V. Vašků, J Bienertová-Vašků, M. Nečas, A. Vašků

. 2009 ; 9 (4) : 327-3231.

Language English Country Italy

Document type Comparative Study

The aim of the study was to evaluate possible association of MTHFR C677T gene polymorphism (NM_005957) with psoriasis. Genotypes of MTHFR C677T gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. Case group (n = 410) included patients with psoriasis (plaque psoriasis diagnosed in 285 patients, other subtypes of psoriasis were observed in 125 patients). Control group (n = 244) consisted of healthy subjects without individual history of psoriasis, with similar age and gender characteristics. The MTHFR C677T polymorphism genotypes were determined by a polymerase chain reaction and a subsequent restriction analysis with HinfI. The genotypes of C(677)T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. We proved a significant difference in genotype distribution (P(g) = 0.03) and allelic frequency (P(a) = 0.02) between psoriatic and control subjects (Table 3). The CC (the thermostabile) genotype was significantly more frequent in psoriatic patients compared to controls [OR = 1.55, 95% confidential interval (CI) = 1.12-2.15, P = 0.004814, P(corr) = 0.01]. But, a significant increase of T allele in MTHFR gene was observed in patients with positive family history of diabetes (P(a) = 0.02) and in those with a frequent tonsillitis/tonsillectomy (P(a) = 0.04). No difference was observed between patients with and without positive family history of psoriasis (P(a) = 0.251). But, when psoriatic patients were described for FHDM, FH-Ps, and PH-T simultaneously, The highest incidence of CT + TT genotypes was calculated for psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy compared to patients without all these three phenotypes (odds ratio = 3.17, 95% CI 1.33-7.56, P(corr) = 0.04). In conclusion, MTHFR C677T polymorphism is marginally associated with psoriasis. The T allele (thermolabile) appears to be more frequent in psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy. This could reflect an inborn predisposition in complex regulation in one-carbon moieties transport in psoriatic patients and therefore, MTHFR genotype can be a part of genetic background of psoriasis.

References provided by Crossref.org

000      
04294naa 2200553 a 4500
001      
bmc11022261
003      
CZ-PrNML
005      
20121203091820.0
008      
110729s2009 it e eng||
009      
AR
024    __
$a 10.1007/s10238-009-0054-0 $2 doi
035    __
$a (PubMed)19484352
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Vašků, Vladimír, $d 1954- $7 nlk20010099074
245    10
$a MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis / $c V. Vašků, J Bienertová-Vašků, M. Nečas, A. Vašků
314    __
$a 1st Department of Dermatology, St. Ann's Faculty Hospital, Masaryk University Brno, Pekarska 53, 656 91, Brno, Czech Republic. vladimir.vasku@fnusa.cz
520    9_
$a The aim of the study was to evaluate possible association of MTHFR C677T gene polymorphism (NM_005957) with psoriasis. Genotypes of MTHFR C677T gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. Case group (n = 410) included patients with psoriasis (plaque psoriasis diagnosed in 285 patients, other subtypes of psoriasis were observed in 125 patients). Control group (n = 244) consisted of healthy subjects without individual history of psoriasis, with similar age and gender characteristics. The MTHFR C677T polymorphism genotypes were determined by a polymerase chain reaction and a subsequent restriction analysis with HinfI. The genotypes of C(677)T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. We proved a significant difference in genotype distribution (P(g) = 0.03) and allelic frequency (P(a) = 0.02) between psoriatic and control subjects (Table 3). The CC (the thermostabile) genotype was significantly more frequent in psoriatic patients compared to controls [OR = 1.55, 95% confidential interval (CI) = 1.12-2.15, P = 0.004814, P(corr) = 0.01]. But, a significant increase of T allele in MTHFR gene was observed in patients with positive family history of diabetes (P(a) = 0.02) and in those with a frequent tonsillitis/tonsillectomy (P(a) = 0.04). No difference was observed between patients with and without positive family history of psoriasis (P(a) = 0.251). But, when psoriatic patients were described for FHDM, FH-Ps, and PH-T simultaneously, The highest incidence of CT + TT genotypes was calculated for psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy compared to patients without all these three phenotypes (odds ratio = 3.17, 95% CI 1.33-7.56, P(corr) = 0.04). In conclusion, MTHFR C677T polymorphism is marginally associated with psoriasis. The T allele (thermolabile) appears to be more frequent in psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy. This could reflect an inborn predisposition in complex regulation in one-carbon moieties transport in psoriatic patients and therefore, MTHFR genotype can be a part of genetic background of psoriasis.
590    __
$a bohemika - dle Pubmed
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a alely $7 D000483
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a diabetes mellitus 2. typu $x genetika $x komplikace $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a frekvence genu $7 D005787
650    _2
$a genotyp $7 D005838
650    _2
$a haplotypy $x genetika $7 D006239
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methylentetrahydrofolátreduktasa (NADPH2) $x genetika $7 D042965
650    _2
$a lidé středního věku $7 D008875
650    _2
$a odds ratio $7 D016017
650    _2
$a fenotyp $7 D010641
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a polymorfismus genetický $x genetika $7 D011110
650    _2
$a polymorfismus délky restrikčních fragmentů $7 D012150
650    _2
$a psoriáza $x genetika $x komplikace $7 D011565
650    _2
$a rizikové faktory $7 D012307
650    _2
$a mladý dospělý $7 D055815
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Dobrovolná, Julie, $d 1979- $7 xx0106895
700    1_
$a Nečas, Miroslav $7 xx0079513
700    1_
$a Vašků, Anna, $d 1954- $7 mzk2006356130
773    0_
$t Clinical & Experimental Medicine $g Roč. 9, č. 4 (2009), s. 327-3231 $w MED00006222
910    __
$a ABA008 $b x $y 2
990    __
$a 20110801121303 $b ABA008
991    __
$a 20121203091851 $b ABA008
999    __
$a ok $b bmc $g 881677 $s 732179
BAS    __
$a 3
BMC    __
$a 2009 $b 9 $c 4 $d 327-3231 $m Clinical and Experimental Medicine $n Clin Exp Med $x MED00006222
LZP    __
$a 2011-4B09/jvme

Find record

Citation metrics

Logged in users only